Upper gastro-intestinal disease in Scotland: A survey of practice amongst Scottish gastroenterologists

Journal of the Royal College of Surgeons of Edinburgh

Volumn 41, Issue 5, 1996, Pages 302-306

  Kubba, A K ^a,b   Whyman, M R ^a  

^a ST JOHN'S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

ARTICLE; BARIUM MEAL; CLINICAL PRACTICE; DUODENUM BLEEDING; DYSPEPSIA; ENDOSCOPIC THERAPY; GASTRITIS; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL SPECIALIST; PEPTIC ULCER; PHYSICIAN; QUESTIONNAIRE; SURGEON; ULCER HEALING; UNITED KINGDOM; UPPER GASTROINTESTINAL TRACT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DYSPEPSIA; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PHYSICIAN'S PRACTICE PATTERNS; SCOTLAND;

EID: 0029829391     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Milne R, Logan RPH, Harwood D, Misiewicz JJ, Forman D. Helicobacter pylori and upper gastro-intestinal disease: a survey of gastroenterologists in the United Kingdom Gut 1995; 37: 314-18.
2. Rokkas T, Karameris A, Mavrogeorgis A et al. Eradication of Helicobacter Pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointestinal Endosc 1995; 41(1): 1-4.
3. Dobrilla G, Zancanella L, Amplatz S. The need for long term treatment for peptic ulcer. Aliment Pharmacol Ther 1993; 7(suppl 2): 3-15.
4. Panos F, Watt R. Current management of bleeding peptic ulcer. Drugs 1993; 46(2): 269-80
5. Taha AS, Dahill S, Sturrock RD, Lee FD, Russell RI: Predicting NSAID related ulcers - the assessment of clinical and pathological risk factors and importance of differences in NSAIDs. Gut 1994; 35: 891-5.
6. Ming-Yu L, Hsien-Hong L, Pang-Chi C. Duodenal ulcer haemorrhage with or without dyspepsia. Am J Gastroenterol 1990; 85(10): 1343-45.
7. Fries JF, Miller SR, Spitz PW et al. Epidemiology of gastropathy associated with non steroidal anti-inflammatory drug use. Gastroenterology 1989; 96: 647-55.
8. Hallas J, Gram LF, Grodum E, Damsbo M, Brosen K, Haghfelt T Drug related hospital admission to medical wards, a population based survey. Br J Clin Pharmacol 1992; 33: 61-8.
9. Axon ATR, Bell GD, Jones RH, Quine MA, McCloy RF. Guidelines on appropriate indications for upper gastro-intestinal endoscopy. Br Med J 1995; 310: 853-56.
10. Green FN, Kaplan HM, Curtus LE et al. Effect of acid and pepsin on blood coagulation and platlet aggregation Gastroenterology 1978; 74: 38-43.
11. Patchell SE, Enright H, Afdhal N et al. Clot lysis by gastric juice: an in vitro study. Gut 1989; 30: 1704-7.
12. Walt RP, Cottrell J, Mann SG, Freemantle NP, Langman MJ. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1991; 340 (8827): 1058-62.
13. Daneshmend TK, Hawkey CJ, Langman MJ et al. Omeprazole versus Placebo for acute upper gastro intestinal bleeding, randomised double blind control trial. Br Med J 1990; 304: 143-7.
14. Bour B, Pariente EA. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicentre randomised study. Gastroenterol Clinique Biol 1993; 17(5): 329-33.
15. Brunner G, Chung J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of upper intestinal tract: an open randomised controlled trial. Digestion 1990; 45(4): 217-25.
16. Panes J, Forne M, Marco C, Viver J, Garcia-Oliveres E, Garau J. Controlled trial of endoscopic sclerotherapy in bleeding peptic ulcers. Lancet 1987; 2: 1292-94.
17. Swain CP, Kirkham JS, Salmon PR, Brown SG, Northfield TC. Controlled trial of Laser Photocoagulation for bleeding peptic ulcer. Lancet 1986; i: 1113-16.
18. Chung SC, Leung J, Sung J, Lo K, Li AK. Heater probe or Adrenaline injection for actively bleeding ulcers. Gastrointest Endosc 1989; 35: 152-6.
19. Liane L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract haemorrhage: a prospective controlled trial. N Engl J Med 1987; 316: 1613-7.
20. Palmer KR, Choudari CP Endoscopic intervention in bleeding peptic ulcer. Gut 1995; 37: 161-64.
21. Boyd EJS, Penston JG, Wormsley KG. Maintenance therapy in duodenal and gastric ulcer disease: a survey of practice amongst British gastroenterologists. Aliment Pharmacol Ther 1992; 6: 727-37.
22. Anon. Helicobacter Pylori infection - When and how to treat. Drug Thera Bull 1993; (31): 4.
23. Labenz J, Borsch J Role of Helicobacter Pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
24. Laporte JR, Carne X, Vidal X et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and non steroidal anti-inflammatory drugs. Lancet 1991; 337. 85-9.
25. Langman MJS, Weil J, Wainwright P et al. Risk of bleeding peptic ulcer associated with individual non steroidal anti-inflammatory drugs. Lancet 1994; 343(8905): 1075-8.
26. Hallas J, Lauriston J, Dalsgard H et al. Non steroidal anti-inflammatory drugs and upper gastrointestinal bleeding, Identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30: 438-44.
27. Weil J, Jones D, Langman M et al Prophylactic Aspirin and risk of peptic ulcer bleeding. Br Med J 1995; 310: 827-30.
28. Penston JG, Crombie I, Waugh N, Wormsley K. Trends in morbidity and mortality from peptic ulcer disease. Aliment Pharmacol Ther 1993; 7: 429-42.
29. Penston JG, Wormsley K. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 1992, 6(5): 629-45.
30. Perez-Mateo M, Sillero C. Comparative study of Sucralfate and Ranitidine in the treatment of bleeding duodenal ulcer. Revista Esp Enfer Digestivas 1991; 80(2): 87-90
31. Williams B, Luckas M. Do young patients with dyspepsia need investigation? Lancet 1988; 2(8624): 1349-51.
32. Bytzer P, Hansen JM, Muckadell OBS. Empirical H2 blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-16.
33. Keingan DD, Bran SR, Hutchison GA Open access gastroscopy: too much to swallow. Br Med J 1990; 10. 374-6.
34. Graham DY, Hepps KS, Ramirez F, Lew G, Saeed A. Treatment of Helicobacter pylori eradication reduces the rate of rebleeding in peptic ulcer disease Scand J Gastroenterol 1993; 28: 939-942.
35. Sung JJ, Chung SC, Ling TK et al. One year follow up of duodenal ulcers after one week triple therapy for Helicobacter pylori. Am J Gastroenterol 1994; 89(2): 199-202.
36. Tytgat GN, Noach LA, Rauws EA, et al: Helicobacter Infection and duodenal ulcer disease (Review). Gastroenterol Clin N America 1993; 22(1): 127-39.
37. Hosking SW, Ling TK, Chung SC et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti acid treatment. Randomised controlled trial Lancet 1994; 343 (8896): 508-10.
38. Jasperson D, Koerrner T, Schorr W et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointestinal Endosc 1995; 41(1): 5-7
39. Mahony M, Wyatt J, Littlewood JM et al. Management in response to treatment of Helicobacter pylori gastritis. Arch Dis Childhood 1992; 67(7): 940-3.